A Medical Device to Treat Brain Aneurysms

Status Completed

Clinical Trial Summary

An aneurysm is a bulge in a blood vessel caused by a weakness in the blood vessel wall, usually where it branches. As blood passes through the weakened blood vessel, the blood pressure causes a small area to bulge outwards like a balloon. Most brain aneurysms only cause noticeable symptoms if they burst (rupture). This leads to an extremely serious condition known as a subarachnoid hemorrhage, where bleeding caused by the ruptured aneurysm can cause extensive brain damage and symptoms. The study aims to evaluate the safety and effectiveness of a medical device to treat brain aneurysms.

Clinical Trial Description

Patients will be treated with the Nautilus, then will be followed up for up to 6 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04963933
Study type	Interventional
Source	EndoStream Medical
Contact
Status	Completed
Phase	N/A
Start date	March 17, 2021
Completion date	April 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04583163` - Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
Recruiting	`NCT03306823` - Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1	N/A
Recruiting	`NCT03306836` - Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2	N/A
Recruiting	`NCT02345395` - Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation Aneurysms	N/A
Completed	`NCT00962546` - Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage	N/A
Recruiting	`NCT04141020` - Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms	Phase 2
Recruiting	`NCT01460563` - Valproic Acid, Magnesium Sulphate, Rocuronium Requirement, Postoperative Analgesia	N/A
Completed	`NCT02507999` - Goal-directed Therapy in Endovascular Coiling of Cerebral Aneurysm Patients	N/A
Recruiting	`NCT02162654` - Remote Ischemic Preconditioning for Intracranial Aneurysm Treatment	N/A
Completed	`NCT01943591` - DELTA Trial: Does Embolization With Larger Coils Lead to Better Treatment of Aneurysms Trial	N/A
Recruiting	`NCT03815149` - Safety and Clinical Effectiveness of Pipeline™ Shield Devices for Intracranial Aneurysms
Completed	`NCT03152201` - New Findings About Somatosensory Evoked Potentials (SEP) During Surgery for Cerebral Aneurysms
Recruiting	`NCT02444832` - Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy	N/A
Active, not recruiting	`NCT05774782` - Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification	N/A
Withdrawn	`NCT01878136` - Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage	Phase 1/Phase 2
Withdrawn	`NCT02011321` - Clevidipine for Vasospasm After Subarachnoid Hemorrhage (SAH)	Phase 2
Completed	`NCT02455440` - Esmolol Infusion in Patients Undergoing Craniotomy	Phase 3
Completed	`NCT00614887` - Hypothalamo-, Pituitary-, Adrenal Axis Dysfunction in Subarachnoid Hemorrhage
Terminated	`NCT02281721` - Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection
Completed	`NCT02700607` - Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity	N/A